logo-loader

Medexus Pharmaceuticals posts strong revenue numbers, trend to continue in 2019

Published: 08:37 17 Jul 2019 EDT

Medexus Pharmaceuticals Inc (TSXV:MDP) (OTCQB:PDDPF) CEO Ken d’Entremont tells Proactive Investors the Canadian company posted fiscal fourth-quarter results, with revenue that more than quintupled year-over-year.

d’Entremont says the drug-maker saw revenue jump to $12.7 million, up from $2.1 million in the prior-year quarter due to its recent M&A activity and revenues coming from its pharma products.

Medexus Pharmaceuticals reveals record quarterly revenue of C$31.5M

Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) CEO Ken d’Entremont tells Proactive its fiscal third quarter results revealed record quarterly revenue of C$31.5M, nearly doubling its revenue year-over-year from C$16.2M in the same period in 2019. d’Entremont added given significant share...

on 03/02/2021